Gregory Gene Freitag Axogen, Inc. (AXGN) insider trading activity

Gregory Gene Freitag is Director of Axogen, Inc.. Currently has a direct ownership of 283,498 shares of AXGN, which is worth approximately $4.61 Million. The most recent transaction as insider was on Jun 04, 2024, when has been sold 11,904 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 283K

0% 3M change

2.29% 12M change

Total Value Held $4.61 Million

Gregory Gene Freitag Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 04 2024	BUY Exercise of conversion of derivative security	-	11,904 Added 4.03%	283,498 Common Stock
Mar 07 2024	SELL Open market or private sale	$225,000 $9.0 p/Share	25,000 Reduced 8.43%	271,594 Common Stock
Jun 01 2023	SELL Open market or private sale	$365,225 $8.7 p/Share	41,980 Reduced 12.64%	290,135 Common Stock
Jun 01 2023	BUY Exercise of conversion of derivative security	-	6,459 Added 2.13%	296,594 Common Stock
May 23 2023	SELL Open market or private sale	$68,854 $9.22 p/Share	7,468 Reduced 2.2%	332,115 Common Stock
Nov 14 2022	SELL Open market or private sale	$165,620 $12.74 p/Share	13,000 Reduced 3.69%	339,583 Common Stock
Nov 08 2022	SELL Open market or private sale	$162,500 $12.5 p/Share	13,000 Reduced 3.56%	352,583 Common Stock
Aug 10 2022	SELL Open market or private sale	$86,194 $9.7 p/Share	8,886 Reduced 2.37%	365,583 Common Stock
Aug 08 2022	SELL Open market or private sale	$135,287 $10.37 p/Share	13,046 Reduced 3.37%	374,469 Common Stock
Aug 04 2022	SELL Open market or private sale	$255,360 $10.64 p/Share	24,000 Reduced 5.83%	387,515 Common Stock
Jul 25 2022	SELL Payment of exercise price or tax liability	$280,541 $9.26 p/Share	30,296 Reduced 6.86%	411,515 Common Stock
Jul 25 2022	BUY Exercise of conversion of derivative security	$280,540 $3.38 p/Share	83,000 Added 15.82%	441,811 Common Stock
Jun 01 2022	BUY Exercise of conversion of derivative security	-	3,036 Added 0.84%	358,811 Common Stock
Jun 17 2021	SELL Payment of exercise price or tax liability	$183,699 $20.92 p/Share	8,781 Reduced 2.41%	355,775 Common Stock
Jun 17 2021	BUY Exercise of conversion of derivative security	$177,323 $19.17 p/Share	9,250 Added 2.47%	364,556 Common Stock
Jun 04 2021	BUY Exercise of conversion of derivative security	$88,080 $3.67 p/Share	24,000 Added 6.33%	355,306 Common Stock
May 26 2021	BUY Exercise of conversion of derivative security	$588,897 $5.72 p/Share	102,954 Added 23.71%	331,306 Common Stock
Feb 25 2021	SELL Open market or private sale	$529,440 $22.06 p/Share	24,000 Reduced 9.51%	228,352 Common Stock
Feb 17 2021	SELL Payment of exercise price or tax liability	$29,490 $18.7 p/Share	1,577 Reduced 0.62%	252,352 Common Stock
Feb 16 2021	BUY Grant, award, or other acquisition	-	5,161 Added 2.0%	252,897 Common Stock
Dec 29 2020	SELL Open market or private sale	$16,314 $17.81 p/Share	916 Reduced 0.37%	248,345 Common Stock
Dec 27 2020	BUY Grant, award, or other acquisition	-	2,300 Added 0.91%	249,261 Common Stock
Dec 21 2020	SELL Open market or private sale	$6,223 $16.42 p/Share	379 Reduced 0.15%	245,076 Common Stock
Dec 18 2020	BUY Grant, award, or other acquisition	-	925 Added 0.38%	245,455 Common Stock

Also insider at

PDSB

PDS Biotechnology Corp Healthcare

LSPR

Larkspur Health Acquisition Corp. Financial Services

Director

GGF